Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eledon Pharmaceuticals, Inc.

2.69
-0.0600-2.18%
Post-market: 2.690.00000.00%19:50 EDT
Volume:7.56M
Turnover:20.33M
Market Cap:161.08M
PE:-8.52
High:2.79
Open:2.77
Low:2.61
Close:2.75
Loading ...
Aug 19, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 19, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Aug 19, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Jul 12, 2024

Major Issues Report

Form 8-K - Current report
Jul 10, 2024

Major Issues Report

Form 8-K - Current report
Jul 10, 2024

Major Issues Report

Form 8-K - Current report
Jun 03, 2024

Correspondence

Form CORRESP - Correspondence
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Major Issues Report

Form 8-K - Current report
Apr 26, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Major Issues Report

Form 8-K - Current report